The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction.
Biomedical Technology
Blood Glucose Self-Monitoring
/ instrumentation
Communication
Congresses as Topic
Delivery of Health Care
Diabetes Mellitus
/ therapy
Digital Technology
Electronic Health Records
Health Services Accessibility
Humans
Insulin Infusion Systems
Mobile Applications
Monitoring, Physiologic
/ instrumentation
Physician-Patient Relations
Telemedicine
AGP
Connected devices
Digital tools
Telemedicine
Type 1 diabetes
Type 2 diabetes
Journal
Diabetes technology & therapeutics
ISSN: 1557-8593
Titre abrégé: Diabetes Technol Ther
Pays: United States
ID NLM: 100889084
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
pubmed:
10
9
2020
medline:
27
2
2021
entrez:
9
9
2020
Statut:
ppublish
Résumé
The increasing prevalence of diabetes, combined with a growing global shortage of health care professionals (HCP), necessitates the need to develop new approaches to diabetes care delivery to expand access to care, lessen the burden on people with diabetes, improve efficiencies, and reduce the unsustainable financial liability on health systems and payers. Use of digital diabetes technologies and telehealth protocols within a digital/virtual diabetes clinic has the potential to address these challenges. However, several issues must be resolved to move forward. In February 2020, organizers of the Advanced Technologies & Treatments for Diabetes Annual Conference convened an international panel of HCP, researchers, patient advocates, and industry representatives to review the status of digital diabetes technologies, characterize deficits in current technologies, and identify issues for consideration. Since that meeting, the importance of using telehealth and digital diabetes technologies has been demonstrated amid the global coronavirus disease (COVID-19) pandemic. This article summarizes the panel's discussion of the opportunities, obstacles, and requisites for advancing the use of these technologies as a standard of care for the management of diabetes.
Identifiants
pubmed: 32905711
doi: 10.1089/dia.2020.0375
pmc: PMC8098767
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
146-154Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK036836
Pays : United States
Références
Lancet. 2016 Nov 5;388(10057):2254-2263
pubmed: 27634581
Telemed J E Health. 2019 Jul;25(7):569-583
pubmed: 30124394
JAMA. 2013 Sep 25;310(12):1240-7
pubmed: 24065010
Lancet. 2017 Nov 25;390(10110):2347-2359
pubmed: 28923465
QJM. 2000 Jun;93(6):369-74
pubmed: 10873187
Diabetes Technol Ther. 2019 Jun;21(S2):S252-S258
pubmed: 31169428
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
J Diabetes Metab Disord. 2020 Jan 10;19(1):115-127
pubmed: 32550161
Diabet Med. 1991 Oct;8(8):773-7
pubmed: 1838071
Diabetes Technol Ther. 2020 Jun;22(6):449-453
pubmed: 32383989
N Engl J Med. 2019 Oct 31;381(18):1707-1717
pubmed: 31618560
J Telemed Telecare. 2020 Jul;26(6):349-355
pubmed: 30871408
Diabetes Ther. 2017 Aug;8(4):863-873
pubmed: 28646411
Diabetes Technol Ther. 2020 Aug;22(8):623-638
pubmed: 32027176
Clin Diabetes. 2020 Oct;38(4):357-362
pubmed: 33132505
Lancet Diabetes Endocrinol. 2017 Sep;5(9):700-708
pubmed: 28711468
Acta Diabetol. 2018 Feb;55(2):185-192
pubmed: 29209814
Diabetes Care. 2020 Aug;43(8):1822-1828
pubmed: 32471910
Prim Care Diabetes. 2017 Feb;11(1):3-12
pubmed: 27727005
Prev Chronic Dis. 2018 Jan 25;15:E13
pubmed: 29369757
Diabetes Technol Ther. 2015 Aug;17(8):542-7
pubmed: 26237308
Int Dig Health Legis. 1998;49(3):502-8
pubmed: 11657540
BMJ. 2018 Apr 18;361:k1310
pubmed: 29669716
Endocr Pract. 2004 Jan-Feb;10(1):67-76
pubmed: 15251625
Diabet Med. 2013 Aug;30(8):901-13
pubmed: 23324062
J Clin Endocrinol Metab. 2014 Dec;99(12):4674-82
pubmed: 25057872
Diabetes Technol Ther. 2011 Nov;13(11):1129-34
pubmed: 21827318
N Engl J Med. 2020 Jun 4;382(23):e82
pubmed: 32240581
BMC Endocr Disord. 2019 Feb 13;19(1):21
pubmed: 30760280
Diabetes Technol Ther. 2017 Mar;19(3):155-163
pubmed: 28134564
Diabetes Obes Metab. 2015 Dec;17(12):1126-32
pubmed: 26179879
Curr Diab Rep. 2019 Nov 25;19(12):148
pubmed: 31768662
Diabetes Obes Metab. 2016 Apr;18(4):401-9
pubmed: 26743666
Metabolism. 2019 Jan;90:20-30
pubmed: 30321535
Diabetes Care. 2017 Apr;40(4):538-545
pubmed: 28209654
Diabetes Ther. 2017 Jun;8(3):573-586
pubmed: 28401454
Diabetes Care. 2020 Jan;43(Suppl 1):S66-S76
pubmed: 31862749
Lancet. 2018 Apr 7;391(10128):1367-1377
pubmed: 29459019
Lancet Diabetes Endocrinol. 2017 Jul;5(7):501-512
pubmed: 28533136
Diabet Med. 2005 Oct;22(10):1379-85
pubmed: 16176200
Diabetes Ther. 2017 Feb;8(1):55-73
pubmed: 28000140
JAMA. 2017 Jan 24;317(4):371-378
pubmed: 28118453
JAMA. 2016 Oct 4;316(13):1407-1408
pubmed: 27629148
Diabetes Care. 2011 Mar;34(3):533-9
pubmed: 21266648
Diabetes Obes Metab. 2018 Feb;20(2):427-437
pubmed: 28834075
J Diabetes Sci Technol. 2017 Nov;11(6):1138-1146
pubmed: 28449590
J Diabetes Sci Technol. 2020 Jul;14(4):822-832
pubmed: 32536205
Diabetes Care. 2018 Feb;41(2):267-276
pubmed: 29183910
Clin Ther. 2006 Oct;28(10):1712-25; discussion 1710-1
pubmed: 17157128
Diabetes Technol Ther. 2016 May;18(5):288-91
pubmed: 26907513
Int J Clin Pract Suppl. 2009 Oct;(164):6-10
pubmed: 19751453
Diabetes Care. 2017 Nov;40(11):1588-1596
pubmed: 28801474
Diabetes Technol Ther. 2009 Jun;11(6):385-92
pubmed: 19459768
Diabetes Technol Ther. 2020 Jun;22(6):444-448
pubmed: 32396395
JAMA. 2017 Jan 24;317(4):379-387
pubmed: 28118454
Diabetologia. 2018 Mar;61(3):539-550
pubmed: 29273897
Ann Intern Med. 2017 Sep 19;167(6):365-374
pubmed: 28828487
Diabetes Care. 2020 Jan;43(1):37-43
pubmed: 31530663
Diabet Med. 2015 Mar;32(3):407-13
pubmed: 25251768
Stud Health Technol Inform. 2007;127:77-90
pubmed: 17901601
Diabetes Technol Ther. 2016 Jan;18(1):7-14
pubmed: 26295939
CMAJ. 2017 Mar 6;189(9):E341-E364
pubmed: 27799615
BMC Pregnancy Childbirth. 2020 Apr 6;20(1):198
pubmed: 32252676